Alto Neuroscience, Inc. (ANRO)
19.48
+1.18
(+6.45%)
USD |
NYSE |
Feb 24, 15:10
Alto Neuroscience Market Cap : 605.17M for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 8.363B |
| Vertex Pharmaceuticals, Inc. | 123.76B |
| Fortress Biotech, Inc. | 114.53M |
| Oramed Pharmaceuticals, Inc. | 137.72M |
| Replimune Group, Inc. | 699.39M |
Market Cap Related Metrics
| PEG Ratio | -1.076 |
| Price to Book Value | 5.425 |
| Price | 19.48 |
| Earnings Yield | -11.81% |
| PEGY Ratio | -1.076 |